Study the universal critical congenital heart disease screening in a peripheral area of Uttarakhand, India

Ravi Sahota, Navpreet Kaur, Gurpal Singh, Veena Joshi, Bharti Gahtori, Divya Mehrotra, Nisha Upadhyay


Background: Congenital heart disease (CHD) is the most frequently occurring congenital disorder, responsible for 28% of all congenital birth defects. The birth prevalence of CHD is reported to be 8-12/1000 live births. Considering a rate of 9/1000, about 1.35 million babies are born with CHD each year globally. Objective of research work to study the prevalence of CHD among newborn and its types.

Methods: This cross-sectional study was carried among 34 cases of CHD/5126 newborn screened at 4 birthing places in Kashipur a small town in Uttrakhand at pediatrics department of Sahota Super-specialty hospital, Kashipur, Uttarakhand. Screening program between 22 August 2014, and March 30, 2019. All newborns, including preterm babies, delivered in these facilities were eligible for inclusion in this study.

Results: Present study found the prevalence of CHD was 0.7 per 1000 children (34/5126). Around 26.5% participants have cyanotic CHD and 73.5% have acynotic CHD. Almost 44%, 28%, 20%, 4% and 4% participants of acynotic congenital heart diseases have VSD, ASD, PDA, AVSD and valvular PS respectively and 55.6%, 22.2%, 11.1% and 11.1% participants of cynotic congenital heart diseases have TOF, DORV/VSD, dTGA/VSD and tricuspid atresia respectively.

Conclusions: Screening for congenital heart disease should be included as a part of newborn assessment as it is a common congenital problem. Early identification influences outcome. Barriers in implementation of the screening programmes in resource limited setting is a challenging feature. This study can provide observed data that can help in policy making in the health sector.


Acyanotic, Congenital heart disease, Cyanotic, Oximetry, Screening, VSD

Full Text:



International Institute for Population Sciences (IIPS) and Macro International. National Family Health Survey (NFHS-3), 2005–06: India: Volume I. Mumbai; IIPS 2007.

Dolk H, Loane M, EUROCAT Steering Committee. Congenital Heart Defect in Europe: 2000-2005. Newtownabbey, Northern Ireland: University of Ulster; March 2009. Available from: Accessed May 18, 2017.

Bernier PL, Stefanescu A, Samoukovic G, Tchervenkov CI. The challenge of congenital heart disease worldwide: epidemiologic and demographic facts. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2010;13:26-34.

Hoffman JIE. The global burden of congenital heart disease. Cardiovascular J Africa. 2013;24:141-5.

Hoffman JIE. Incidence of congenital heart disease: I. Postnatal incidence. Pediatr Cardiol. 1995;16:103-13.

Mellander M, Sunnegardh J. Failure to diagnose critical heart malformations in newborns before dis-charge-an increasing problem? Acta Paediatr. 2006;95(4):407-13.

Mahle WT, Newburger JW, Matherne GP, Smith FC, Hoke TR, Koppel R, et al. Role of pulse oximetryin examining newborns for congenital heart disease: a scientific statement from the American Heart Association and American Academy of Pediatrics. Circulation. 2009;120(5):447-58.

Kemper AR, Mahle WT, Martin GR, Cooley WC, Kumar P, Morrow WR, et al. Strategies for implementing screening for critical congenital heart disease. Pediatrics. 2011;128(5):e1259-67.

Thangaratinam S, Daniels J, Ewer AK, Zamora J, Khan KS. Accuracy of pulse oximetry in screening forcongenital heart disease in asymptomatic newborns: a systematic review. Arch Dis Child Fetal Neona-tal Ed. 2007;92(3):F176-80.

Ewer AK. Review of pulse oximetry screening for critical congenital heart defects in newborn infants.Curr Opin Cardiol. 2013;28(2):92-6.

Thangaratinam S, Brown K, Zamora J, Khan KS, Ewer AK. Pulse oximetry screening for critical con-genital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis. Lancet. 2012;379(9835):2459-64.

Vaidyanathan B, Sathish G, Mohanan ST, Sundaram KR, Warrier KK, Kumar RK. Clinical screening for congenital heart disease at birth: A prospective study in a community hospital in Kerala. Indian Pediatr. 2011;48:25-30.

Sawant SP, Amin AS, Bhat M. Prevalence, pattern and outcome of congenital heart disease in Bhabha atomic research centre hospital. Indian J Pediatr. 2013;80:286-91.

Gupta I, Gupta ML, Parihar A, Gupta CD. Epidemiology of rheumatic and congenital heart disease in rural children. J Indian Med Assoc. 1992;90:57-9.

Vashishtha VM, Kalra A, Kalra K, Jain VK. Prevalence of congenital heart disease in school children. Indian Pediatr. 1993;30:1337-40.

Saxena A. Echocardiographic prevalence of congenital cardiac malformations among 14,716 asymptomatic school children in India. Presented at EuroEcho Imaging; 2013.

Nisale SH, Maske GM. A study of prevalence and pattern of congenital heart disease and rheumatic heart disease among school children. Int J Adv Med. 2016;3:947-51.

Abqari S, Gupta A, Shahab T, Rabbani MU, Ali SM, Firdaus U. Profile and risk factors for congenital heart defects: A study in a tertiary care hospital. Annals Pediatr Cardiol. 2016;9(3):216.

Hussain M, Tahura S, Sayeed MA, Rahman MM, Kar SK. Past and present pattern of congenital heart disease at DSH: A situation analysis. Bangladesh J Child Health. 2010;34:51-5.

Mir AB, Ahmed K, Jan M, Radakrishnan S. Spectrum of congenital heart disease in a tertiary care centre of Northern India. Int J Contemp Pediatr. 2019;6:927-31.

Bhat NK, Dhar M, Kumar R, Patel A, Rawat A, Kalra BP, et al. Prevalence and pattern of congenital heart disease in Uttarakhand, India. Indian J Pediatr. 2013;80:281-5.

Patra S, Sastry UM, Mahimaiha J, Subramanian AP, Shankarappa RK, Nanjappa MC. Spectrum of cyanotic congenital heart disease diagnosed by echocardiographic evaluation in patients attending paediatric cardiology clinic of a tertiary cardiac care centre. Cardio Young. 2015;25(5):861-7.